Michele Ayans, PA

Michele Ayans practices at The Center For Restorative Dermatology in Ventura, California.

Michele Ayans' NPI, 1730340977, was assigned on June 20, 2008. Michele Ayans holds California license PA14834.

Michele Ayans' primary practice is The Center for Restorative Dermatology, at 1190 S Victoria Ave Suite 300 Suite 300, Ventura, CA 93003-6545. The practice phone is (805) 677-1600.

Michele Ayans' primary practice is The Center For Restorative Dermatology in Ventura, California. The medical group on file is Ventura Institute for Dermatologic Arts.

Dmand AI tracks the electronic health record (EHR) system at each site where Michele Ayans practices. Vendor and product names are available with a free account.

Physician assistant is Michele Ayans' primary specialty in the NPI Registry, under taxonomy code 363A00000X. Michele Ayans is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Michele Ayans is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, itchy rashes, psoriasis and scalp rash among the conditions Michele Ayans treats.

CMS data shows 4,413 Medicare services from Michele Ayans across 15 procedure codes in 2024, for 680 Medicare patients. Medicare paid $130,582 for them. Every service was in an office.

CMS counts 680 Medicare patients who saw Michele Ayans in 2024. The largest group is 65 to 74, with 386 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michele Ayans' median patient age at 70, with 65% women.

In 2024, Michele Ayans wrote 383 Medicare Part D claims for 181 patients. 95% of them were for generic drugs. CMS names the drug for 287 of them, across 10 drugs with 11 or more claims each, at $6,107 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Michele Ayans for performance year 2024, reported individually. Michele Ayans accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Michele Ayans from 5 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $68.